1. Home
  2. CGEN vs MPTI Comparison

CGEN vs MPTI Comparison

Compare CGEN & MPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • MPTI
  • Stock Information
  • Founded
  • CGEN 1993
  • MPTI 1965
  • Country
  • CGEN Israel
  • MPTI United States
  • Employees
  • CGEN 74
  • MPTI N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • MPTI
  • Sector
  • CGEN Health Care
  • MPTI
  • Exchange
  • CGEN Nasdaq
  • MPTI Nasdaq
  • Market Cap
  • CGEN 125.3M
  • MPTI 127.2M
  • IPO Year
  • CGEN 2000
  • MPTI N/A
  • Fundamental
  • Price
  • CGEN $1.38
  • MPTI $47.65
  • Analyst Decision
  • CGEN
  • MPTI
  • Analyst Count
  • CGEN 0
  • MPTI 0
  • Target Price
  • CGEN N/A
  • MPTI N/A
  • AVG Volume (30 Days)
  • CGEN 238.3K
  • MPTI 31.8K
  • Earning Date
  • CGEN 11-11-2025
  • MPTI 11-12-2025
  • Dividend Yield
  • CGEN N/A
  • MPTI N/A
  • EPS Growth
  • CGEN N/A
  • MPTI 45.88
  • EPS
  • CGEN N/A
  • MPTI 2.57
  • Revenue
  • CGEN $22,144,000.00
  • MPTI $52,033,000.00
  • Revenue This Year
  • CGEN N/A
  • MPTI $12.06
  • Revenue Next Year
  • CGEN $159.40
  • MPTI $7.34
  • P/E Ratio
  • CGEN N/A
  • MPTI $18.44
  • Revenue Growth
  • CGEN N/A
  • MPTI 16.52
  • 52 Week Low
  • CGEN $1.13
  • MPTI $27.97
  • 52 Week High
  • CGEN $2.66
  • MPTI $60.00
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 41.92
  • MPTI 60.66
  • Support Level
  • CGEN $1.39
  • MPTI $46.16
  • Resistance Level
  • CGEN $1.47
  • MPTI $48.91
  • Average True Range (ATR)
  • CGEN 0.06
  • MPTI 1.53
  • MACD
  • CGEN -0.00
  • MPTI 0.30
  • Stochastic Oscillator
  • CGEN 33.33
  • MPTI 76.94

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

Share on Social Networks: